About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 875 record(s)
Req # A-2021-002146
The Health Canada approved package insert for Dehydrated Alcohol Injection USP (Drug Identification Number (DIN) 00394394) owned by Flon Laboratoires Inc.Organization: Health Canada
December 2022
Req # A-2022-001092
Health Canada International Affairs Team, Strategic Horizontal Policy Division, Health Products and Food Branch. the International Affairs Team, position number 00157831. How many new employees were hired under this position from the periods of 2017-2019 and 2019-2022. The rate of how long they stayed.Organization: Health Canada
December 2022
Req # A-2022-000716
Adverse Drug Reaction (ADR) for Entyvio. Report number: E2B_05505099.Organization: Health Canada
November 2022
Req # A-2022-000734
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-075252-54, Assessment of Modern Treaty Implications - Compliance.Organization: Health Canada
November 2022
Req # A-2022-000846
Adverse Drug Reactions (ADRs) for SINGULAIR. Report numbers: E2B_01279129, E2B_01326513.Organization: Health Canada
November 2022
Req # A-2022-000887
Adverse Drug Reaction (ADR). Report number: E2B_02402316.Organization: Health Canada
November 2022
Req # A-2018-001625
In March 2018, and in the Fall of 2018, patients at the Duval Clinic in Laval Quebec received an osseointegrated implant also known as a bone-anchored prosthesis. The devices were approved under the custom device approval process. Documents requesting that approval and also any report or assessment performed by Health Canada staff that led to the custom device approval.Organization: Health Canada
November 2022
Req # A-2022-000931
All responses to the consultation at the Opioid Symposium in 2018 to gather feedback from stakeholders on Health Canada’s intention to further restrict marketing and advertising of opioids to health care professionals. https://www.canada.ca/en/health-canada/services/opioids/responding-canada-opioid-crisis/advertising-opioid-medications/symposium-summary.htmlOrganization: Health Canada
November 2022
Req # A-2020-001179
All records regarding the Regulatory Review of Drugs and Devices initiative, otherwise known as R2D2, provided to the Minister from June 1, 2019 to November 18, 2020.Organization: Health Canada
October 2022
Req # A-2022-000338
Financial information on the Federally Funded Health Information systems in Canada. Total cost / expense broken down by year ending 2017, 2018, 2019, 2020 & 2021 for all money paid on: Federal Health Transfers to provinces. Federal Health IT Research systems. Federal Health data transfer/ collection/ management systems. Federal Payments & any known Provincial payments to Canada Health Infoway & separately services they have arranged. A total of all money transferred, granted, gifted to Canada Health Infoway from inception in 2001 to June 14th 2022.Organization: Health Canada
October 2022